Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 16, 2026

UBS resets silver price target for rest of 2026

View original at finance.yahoo.com
UBS resets silver price target for rest of 2026 Silver hit an all-time high of $121.64 on January 29. By May 14, it was trading at $84, having briefly cleared $87 the day before on US-China tariff optimism before April CPI data pulled it back…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • UBS lowered its end-Q2 2026 silver price target from $100 to $85, end-Q3 from $95 to $85, year-end from $85 to $80, and March 2027 forecast from $85 to $75

    60% confidence
  • The easy part of the silver trade may already be over

    60% confidence
  • Silver is expected to trade broadly sideways for the remainder of 2026

    60% confidence
  • The 2026 global silver supply deficit is estimated at 60-70 million ounces, down from a prior estimate of approximately 300 million ounces — an 80% reduction

    60% confidence
  • Three demand headwinds — reduced photovoltaic demand, lower silverware and jewelry demand, and reduced investment demand — will reduce silver consumption by approximately 50 million ounces in 2026

    60% confidence
  • For 2026, weaker demand from photovoltaics is expected due to elevated prices

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com